✦ LIBER ✦

Lipoprotein-Associated Phospholipase A2 and Risk Stratification for Cardiovascular Disease: Not Ready for “Prime Time”

✍ Scribed by Steinberg, Daniel I.; Mayer, Alexander

Book ID: 123142612
Publisher: Mayo Clinic
Year: 2007
Tongue: English
Weight: 49 KB
Volume: 82
Category: Article
ISSN: 0025-6196
DOI: 10.4065/82.2.155

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lipoprotein-Associated Phospholipase A2:

Lipoprotein-Associated Phospholipase A2: A Promising Vascular-Specific Marker for Screening Cardiovascular Risk?

✍ Joung Hee Lee; Marguerite M. Engler 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB

Prolonged QRS duration and sudden cardia

Prolonged QRS duration and sudden cardiac death risk stratification: Not yet ready for prime time

✍ Extramiana, Fabrice; Leenhardt, Antoine 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 84 KB

Lipoprotein associated phospholipase A2:

Lipoprotein associated phospholipase A2: role in atherosclerosis and utility as a biomarker for cardiovascular risk

✍ Kenneth J. Colley; Robert L. Wolfert; Michael E. Cobble 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 656 KB

Prognostic Utility of Lipoprotein-Associ

Prognostic Utility of Lipoprotein-Associated Phospholipase A2 for Cardiovascular Outcomes in Patients With Stable Coronary Artery Disease

✍ Sabatine, M. S.; Morrow, D. A.; O'Donoghue, M.; Jablonksi, K. A.; Rice, M. M.; S 📂 Article 📅 2007 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 639 KB

Lipoprotein-associated phospholipase A2:

Lipoprotein-associated phospholipase A2: a potential new risk factor for coronary artery disease and a therapeutic target

✍ Colin H Macphee 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 524 KB

Lipoprotein-associated phospholipase A2:

Lipoprotein-associated phospholipase A2: Pathogenic mechanisms and clinical utility for predicting cardiovascular events

✍ Vijay Nambi; Christie M. Ballantyne 📂 Article 📅 2006 🏛 Current Science Inc. 🌐 English ⚖ 527 KB